HTG Molecular Diagnostics EdgeSeq Diffuse Large B-Cell Lymphoma Cell of Origin Assay

HTG Molecular Diagnostics has introduced the HTG EdgeSeq Diffuse Large B-Cell Lymphoma Cell of Origin assay. The test, which is for research use only, classifies DLBCL into one of the two major subtypes: activated B-cell-like or germinal center B-cell-like. The assay is performed on the automated HTG EdgeSeq system, and couples the company's proprietary nuclease protection chemistry with next-generation sequencing. The test was validated on more than 250 cases previously subtyped through microarray-based gene expression profiling, HTG said.